Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
数字之外：13位分析师讨论辉瑞股票
The perception of Pfizer by...Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Pfizer (NYSE:PFE) in the last three months.
在过去三个月里，13位分析师发布了对辉瑞（NYSE:PFE）股票的看好到看淡的多种观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $39.77, along with a high estimate of $45.00 and a low estimate of $30.00. Witnessing a positive shift, the current average has risen by 2.58% from the previous average price target of $38.77.
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $39.77, along with a high estimate of $45.00 and a low estimate of $30.00. Witnessing a positive shift, the current average has risen by 2.58% from the previous average price target of $38.77.
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
The perception of Pfizer by...
通过最近的...
登录免费看全文
登录/注册
资讯热榜
更新时间